Current:Home > News'Today' show's Jill Martin says she likely is cancer-free, but may undergo chemo -Wealth Legacy Solutions
'Today' show's Jill Martin says she likely is cancer-free, but may undergo chemo
SafeX Pro Exchange View
Date:2025-03-11 07:30:32
"Today" show contributor Jill Martin reveals there is a "good chance" she is now cancer-free, though she may need to undergo chemotherapy, as she continues to chronicle a breast cancer journey that began in June when she was diagnosed with a BRCA gene mutation.
"What an earth-shattering six weeks. It feels like both yesterday and a lifetime since the last time I walked into Studio 1A," she wrote in her latest update on the "Today" site Monday.
"The surgery was three weeks ago," she wrote. "Honestly, physically, I am doing OK. (Emotionally is a different story; it's been a roller coaster.) My double mastectomy was successful. A week after my surgery, my 45-minute meeting with my oncologist, Dr. Joseph Sparano at Mount Sinai in New York City, started with the news that there is a good chance I am cancer-free, but I need further treatment to help ensure that."
Martin said that the messages of support and encouragement from fans have been critical to her well-being. She also stressed that despite the understandable fear associated with being tested for genetic mutations, the potential life-saving benefits make it worthwhile.
"I have gotten word from so many of you that you got tested for gene mutations and have gotten your results back," Martin said. "Most of you have received good news, and some of you have tested positive and are now deciding what to do. After going through this first part of my treatment, I understand it is such a personal choice because everyone’s circumstances, diagnosis and outlook are very different. But again, it should be your choice.
"The most important message from me? Many dear friends, viewers and family have said, 'I am afraid to have any kind of genetic testing, as I am afraid of what I will find out.' I totally understand that sentiment and reasoning. But let me be very clear: Any preventative measures you can take, although not easy, are easier than battling cancer."
Martin, who has a family history of breast cancer, took an at-home genetic test for the BRCA test and had forgotten about it by the time the results came in, she said. BRCA gene mutations can indicate a patient has a higher risk of developing cancers like breast cancer or ovarian cancer, according to the Centers for Disease Control and Prevention.
"My grandmother passed away from breast cancer. And my beautiful mother — who is healthy now — had a double mastectomy in her late 40s after being diagnosed with ductal carcinoma in situ, often referred to as stage 0 breast cancer," Martin wrote in a previous posting about her cancer journey.
'Today' show's Jill Martinopens up about breast cancer diagnosis, will undergo mastectomy
Her mother tested negative for BRCA gene mutations. But BRCA mutations can be carried paternally, too. As a result, Martin's doctors suggested she take the test, which she said "saved my life." The test revealed she has a BRCA2 gene mutation, which her father also has.
Martin still has an arduous path ahead of her.
"I do already know for sure I will need to have another surgery, preventatively, to remove my ovaries and fallopian tubes to decrease my risk of ovarian cancer," she wrote. "In my case, I will need a full hysterectomy, as I have had fibroid issues in the past. I will also need to take anti-hormonal drugs for 5 years. And I will most likely need chemotherapy because of the aggressiveness of the tumor. That is the part that hit me the hardest — the idea of chemo."
Martin said she'll likely be on and off the air for the next six months, but will continue to share written updates.
Contributing: Morgan Hines
veryGood! (74269)
Related
- Opinion: Gianni Infantino, FIFA sell souls and 2034 World Cup for Saudi Arabia's billions
- Biden to meet in-person Wednesday with families of Americans taken hostage by Hamas
- Former Iowa deputy pleads guilty in hot-vehicle death of police dog
- Fed expected to stand pat on interest rates but forecast just two cuts in 2024: Economists
- Will the 'Yellowstone' finale be the last episode? What we know about Season 6, spinoffs
- ‘I feel trapped': Scores of underage Rohingya girls forced into abusive marriages in Malaysia
- Why George Clooney Is at a Tactical Disadvantage With His and Amal Clooney's Kids
- Guy Fieri talks Super Bowl party, his son's 'quick engagement' and Bobby Flay's texts
- Angelina Jolie nearly fainted making Maria Callas movie: 'My body wasn’t strong enough'
- Chargers QB Justin Herbert out for remainder of season with fractured index finger
Ranking
- Former Danish minister for Greenland discusses Trump's push to acquire island
- 'This is completely serious': MoonPie launches ad campaign targeting extraterrestrials
- Haley gets endorsement from Gov. Chris Sununu ahead of pivotal New Hampshire primary
- Ambush kills 7 Israeli soldiers in Gaza City, where battles rage weeks into devastating offensive
- John Galliano out at Maison Margiela, capping year of fashion designer musical chairs
- Quarter of world's freshwater fish species at risk of extinction, researchers warn
- Amid outcry over Gaza tactics, videos of soldiers acting maliciously create new headache for Israel
- Newly elected progressive Thai lawmaker sentenced to 6 years for defaming monarchy
Recommendation
Current, future North Carolina governor’s challenge of power
Norfolk, Virginia, approves military-themed brewery despite some community pushback
AT&T Stadium employee accused of letting ticketless fans into Cowboys-Eagles game for cash
We Went to the First EV Charging Station Funded by the Federal Infrastructure Law
Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Triathlon
Man shoots woman and 3 children, then himself, at Las Vegas apartment complex, police say
Are Ye and Ty Dolla $ign releasing their 'Vultures' album? What to know amid controversy
Are post offices, banks, shipping services open on Christmas Eve and Christmas Day 2023?